BR112016014010A2 - métodos para detectar anticorpos contra vírus da febre suína clássica tipo selvagem (csfv), para diferenciação entre animais infectados com csfv tipo selvagem e animais que foram vacinados contra csfv e para controlar uma infecção com csfv tipo selvagem, kit de teste de diagnóstico, e, uso de um carreador - Google Patents
métodos para detectar anticorpos contra vírus da febre suína clássica tipo selvagem (csfv), para diferenciação entre animais infectados com csfv tipo selvagem e animais que foram vacinados contra csfv e para controlar uma infecção com csfv tipo selvagem, kit de teste de diagnóstico, e, uso de um carreadorInfo
- Publication number
- BR112016014010A2 BR112016014010A2 BR112016014010A BR112016014010A BR112016014010A2 BR 112016014010 A2 BR112016014010 A2 BR 112016014010A2 BR 112016014010 A BR112016014010 A BR 112016014010A BR 112016014010 A BR112016014010 A BR 112016014010A BR 112016014010 A2 BR112016014010 A2 BR 112016014010A2
- Authority
- BR
- Brazil
- Prior art keywords
- csfv
- wild
- type
- animals
- test kit
- Prior art date
Links
- LXWYCLOUQZZDBD-LIYNQYRNSA-N csfv Chemical compound C([C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O)C1=CC=C(O)C=C1 LXWYCLOUQZZDBD-LIYNQYRNSA-N 0.000 title abstract 11
- 238000000034 method Methods 0.000 title abstract 6
- 241001465754 Metazoa Species 0.000 title abstract 4
- 238000002405 diagnostic procedure Methods 0.000 title abstract 3
- 208000015181 infectious disease Diseases 0.000 title abstract 2
- 241000710777 Classical swine fever virus Species 0.000 title 1
- 239000003550 marker Substances 0.000 abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 2
- 238000001514 detection method Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/02—Recovery or purification
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/22—Vectors comprising a coding region that has been codon optimised for expression in a respective host
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/18—Togaviridae; Flaviviridae
- G01N2333/183—Flaviviridae, e.g. pestivirus, mucosal disease virus, bovine viral diarrhoea virus, classical swine fever virus (hog cholera virus) or border disease virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
Abstract
a presente invenção se refere ao campo de diagnóstico veterinário, especificamente a um teste para a detecção de anticorpos contra csfv. em particular, a invenção se refere a um método para detectar anticorpos contra csfv tipo selvagem em uma amostra de teste, distinguido pelo fato de que o método compreende coincubação com um carreador compreendendo um epítopo tavspttlr mutado de proteína e2 do csfv. adicionalmente, a invenção se refere a um kit de teste de diagnóstico e ao uso do método de acordo com a invenção. além do mais, a invenção se refere a um método para diferenciação entre animais infectados com csfv tipo selvagem e animais que foram vacinados contra csfv com uma vacina contra csfv (marcador), e a um método para controlar uma infecção com csfv tipo selvagem em uma população de animais suínos, pelo uso combinado de uma vacina contra csfv (marcador) e o kit de teste de diagnóstico da invenção.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13198615.0 | 2013-12-19 | ||
EP13198615 | 2013-12-19 | ||
PCT/EP2014/078373 WO2015091736A1 (en) | 2013-12-19 | 2014-12-18 | Improved diagnostic test for csfv antibodies |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112016014010A2 true BR112016014010A2 (pt) | 2018-01-09 |
BR112016014010B1 BR112016014010B1 (pt) | 2022-08-30 |
Family
ID=49885010
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112016014010-9A BR112016014010B1 (pt) | 2013-12-19 | 2014-12-18 | Método para detectar anticorpos contra vírus da febre suína clássica tipo selvagem (csfv) em uma amostra de teste e kit de teste de diagnóstico |
Country Status (11)
Country | Link |
---|---|
US (1) | US9739778B2 (pt) |
EP (1) | EP3084441B1 (pt) |
JP (1) | JP6383422B2 (pt) |
KR (1) | KR101848194B1 (pt) |
CN (1) | CN105829892B (pt) |
BR (1) | BR112016014010B1 (pt) |
ES (1) | ES2668459T3 (pt) |
HU (1) | HUE038721T2 (pt) |
RU (1) | RU2689143C1 (pt) |
TW (1) | TWI611188B (pt) |
WO (1) | WO2015091736A1 (pt) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6383422B2 (ja) * | 2013-12-19 | 2018-08-29 | インターベット インターナショナル ベー. フェー. | Csfv抗体に関する改善された診断試験 |
CN106383226A (zh) * | 2016-08-19 | 2017-02-08 | 金宇保灵生物药品有限公司 | 猪血清中猪瘟中和抗体效价的定量检测方法及检测试剂盒 |
CN107064501B (zh) * | 2017-05-02 | 2019-04-16 | 中国农业科学院兰州兽医研究所 | 一种定量检测猪瘟病毒IgG抗体竞争ELISA试剂盒及其检测方法 |
CN107828745B (zh) * | 2017-11-15 | 2021-01-05 | 中国兽医药品监察所 | 猪瘟兔化弱毒表位突变株及其应用 |
WO2020211801A1 (en) * | 2019-04-18 | 2020-10-22 | Boehringer Ingelheim Vetmedica (China) Co., Ltd. | Recombinant classical swine fever virus |
CN111044494B (zh) * | 2019-11-26 | 2022-08-23 | 安徽云燕食品科技有限公司 | 一种猪瘟的快速检测方法 |
CN112375126B (zh) * | 2020-11-04 | 2022-07-29 | 天康生物制药有限公司 | 标记猪瘟病毒e2蛋白重组杆状病毒灭活疫苗 |
CN114236128B (zh) * | 2021-11-30 | 2022-07-29 | 中国农业科学院兰州兽医研究所 | 一种检测猪急性腹泻综合征冠状病毒n蛋白抗体的阻断elisa试剂盒 |
CN116068175B (zh) * | 2022-09-07 | 2024-06-07 | 中国农业科学院兰州兽医研究所 | 一种基于e2蛋白二聚体的猪瘟病毒管式化学发光抗体检测试剂盒及其应用 |
CN116953234B (zh) * | 2023-08-25 | 2024-05-17 | 中国农业科学院兰州兽医研究所 | 一种猪博卡病毒g3型的多肽-elisa抗体检测试剂盒 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ287563A (en) * | 1994-06-17 | 1998-08-26 | Inst Veehouderij Diergezondh | Dna sequence of classical swine fever virus (csfv), vaccine and diagnostic test |
US7763460B2 (en) * | 2005-06-24 | 2010-07-27 | Focus Diagnostics, Inc. | Methods and compositions for detecting herpes simplex virus type 2 |
US8846055B2 (en) | 2006-05-30 | 2014-09-30 | The United States Of America, As Represented By The Secretary Of Agriculture | Virulence determinant within the E2 structural glycoprotein of classical swine fever virus |
CN101144818B (zh) * | 2007-10-19 | 2011-04-27 | 清华大学 | 检测猪瘟病毒特异性抗体的方法及其酶联免疫试剂盒 |
EP2127678A1 (en) * | 2008-05-26 | 2009-12-02 | Roche Diagnostics GmbH | SlpA as a tool for recombinant protein and enzyme technology |
MX2011002870A (es) * | 2008-09-17 | 2011-04-26 | Intervet Int Bv | Mutante de pestivirus con mutaciones en gen nuclear y region ns3. |
EP2202298A1 (en) * | 2008-12-23 | 2010-06-30 | Stichting Dienst Landbouwkundig Onderzoek | Recombinant classical swine fever virus (CSFV) comprising a modified E2 protein and methods for generating said recombinant CSFV |
BR112014004261B8 (pt) * | 2011-08-24 | 2022-11-08 | Zoetis Llc | Diagnósticos de vacina melhorada |
JP6383422B2 (ja) * | 2013-12-19 | 2018-08-29 | インターベット インターナショナル ベー. フェー. | Csfv抗体に関する改善された診断試験 |
-
2014
- 2014-12-18 JP JP2016540569A patent/JP6383422B2/ja active Active
- 2014-12-18 KR KR1020167016192A patent/KR101848194B1/ko active IP Right Grant
- 2014-12-18 WO PCT/EP2014/078373 patent/WO2015091736A1/en active Application Filing
- 2014-12-18 RU RU2016129161A patent/RU2689143C1/ru active
- 2014-12-18 EP EP14815702.7A patent/EP3084441B1/en active Active
- 2014-12-18 ES ES14815702.7T patent/ES2668459T3/es active Active
- 2014-12-18 TW TW103144388A patent/TWI611188B/zh active
- 2014-12-18 HU HUE14815702A patent/HUE038721T2/hu unknown
- 2014-12-18 US US15/104,406 patent/US9739778B2/en active Active
- 2014-12-18 CN CN201480069404.4A patent/CN105829892B/zh active Active
- 2014-12-18 BR BR112016014010-9A patent/BR112016014010B1/pt active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
TWI611188B (zh) | 2018-01-11 |
JP6383422B2 (ja) | 2018-08-29 |
TW201530141A (zh) | 2015-08-01 |
CN105829892A (zh) | 2016-08-03 |
HUE038721T2 (hu) | 2018-11-28 |
BR112016014010B1 (pt) | 2022-08-30 |
ES2668459T3 (es) | 2018-05-18 |
KR101848194B1 (ko) | 2018-04-11 |
US20160313330A1 (en) | 2016-10-27 |
WO2015091736A1 (en) | 2015-06-25 |
RU2016129161A (ru) | 2018-01-24 |
EP3084441A1 (en) | 2016-10-26 |
EP3084441B1 (en) | 2018-03-28 |
JP2017503165A (ja) | 2017-01-26 |
US9739778B2 (en) | 2017-08-22 |
CN105829892B (zh) | 2018-06-12 |
RU2689143C1 (ru) | 2019-05-24 |
KR20160097219A (ko) | 2016-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112016014010A2 (pt) | métodos para detectar anticorpos contra vírus da febre suína clássica tipo selvagem (csfv), para diferenciação entre animais infectados com csfv tipo selvagem e animais que foram vacinados contra csfv e para controlar uma infecção com csfv tipo selvagem, kit de teste de diagnóstico, e, uso de um carreador | |
BR112017010268A2 (pt) | agente de ligação; composição de diagnóstico; kit de diagnóstico; métodos de diagnóstico de uma infecção bacteriana ou de diferenciação entre uma infecção bacteriana e uma infecção de viral; para descartar uma infecção bacteriana em um indivíduo; para descartar uma infecção viral em um indivíduo; para considerar uma infecção bacteriana em um indivíduo; para considerar uma infecção viral em um indivíduo; para distinguir entre uma infecção bacteriana ou mista e uma infecção viral em um indivíduo; para fornecer uma recomendação de tratamento para um indivíduo; para fornecer uma recomendação de teste de diagnóstico para um indivíduo; para descartar uma doença infecciosa; para identificação do tipo de infecção; e dispositivo para o diagnóstico de infecções bacterianas | |
MX2018009738A (es) | Anticuerpos monoclonales de proteína ns1 anti-virus del dengue. | |
BR112018000696A2 (pt) | ?anticorpo, métodos para reduzir e para aumentar a afinidade de ligação de um anticorpo que se liga ao cd3 humano, para tratar e para diagnosticar uma doença, para produzir um anticorpo e para detectar a presença de antígeno de cd3, construto de ácido nucleico, vetor de expressão, célula hospedeira, composição, e, kit? | |
CO6640258A2 (es) | Formulaciones de anticuerpos de alta concentración | |
BR112017002209A2 (pt) | método e kit para detectar uma infecção pelo vírus da dengue | |
EA201790165A1 (ru) | Происходящие от человека антитела к гентингтину (htt) и их применение | |
BR112015026246A2 (pt) | dispositivo de transferência de coleta de sangue e separação de sangue e sistema de teste | |
BR112018075513A2 (pt) | ácidos nucleicos que codificam as partículas seme-lhantes ao vírus da zika e seu uso nas vacinas e no ensaio de diagnóstico do vírus da zika | |
BR112018010764A2 (pt) | método para detectar atividade bacteriana em uma amostra biológica e unidade de detecção correspondente | |
Van Rijn et al. | Bluetongue virus with mutated genome segment 10 to differentiate infected from vaccinated animals: a genetic DIVA approach | |
MY181007A (en) | Scale drop disease (sdd) causative virus and derivatives thereof | |
BR112014004261B8 (pt) | Diagnósticos de vacina melhorada | |
BR112017014491A2 (pt) | ?métodos para detectar um marcador para tuberculose ativa? | |
EA201991843A1 (ru) | Способ иммунологического определения специфических антител к антигенам вирусов семейства поксвирусов | |
MX2016017136A (es) | Composiciones y metodos para detectar pegivirus 2 de humano (hpgv-2). | |
GB2541596A (en) | Method and composition for determining specific antibody responses to species of filovirus | |
CY1124297T1 (el) | Ορολογικη εξεταση για τον ελεγχο της θεραπειας καρκινωματος θετικου σε hpv16 | |
BR112015004085A2 (pt) | método para cultivar uma cepa de rotavírus (rv); método para gerar uma rv3 atenuada em células vero; rv3 adaptada à vero isolada; composição de rv morto ou vivo atenuado; método para vacinar um indivíduo humano contra infecção por rv; método para tratar um indivíduo humano com uma infecção por rv ou em risco de desenvolver uma infecção ou reinfecção por rv; uso da rv3 de vero; anticorpo isolado; e método para detectar ou monitorar a rv3 de vero | |
PL401502A1 (pl) | Epitop i jego zastosowanie | |
Nguyen et al. | PRRS in Vietnam and its diagnosis | |
Yilmaz | Molecular Diagnosis and Seroepidemiology of Bovine Viral Diarrhoea Virus in Cattle with Abortion Problem | |
Chen et al. | The relevance of rainfall and leptospiral seropositive rate in regional shelter dogs in Yilan county, Taiwan | |
MX2020006327A (es) | Deteccion de vacunas vivas modificadas contra el virus de la gripe porcina. | |
Aydın et al. | Seroprevalence of avian reovirus infections in chicken enterprises in Balikesir and Bolu provinces of Turkey. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 18/12/2014, OBSERVADAS AS CONDICOES LEGAIS |